Company Profiles

driven by the PitchBook Platform

Carmot Therapeutics

Description

Developer of drugs for the treatment of metabolic diseases, cancer and inflammation. The company offers a technology that enables the identification of drugs through a lead-identification paradigm, which helps in the discovery of therapeutics.

2010

Founded

PRIVATE

Status

1-10

Employees

Grant

Latest Deal Type

$2.05M

Total Amount Raised

5

Investors

Description

Developer of drugs for the treatment of metabolic diseases, cancer and inflammation. The company offers a technology that enables the identification of drugs through a lead-identification paradigm, which helps in the discovery of therapeutics.

Website:

www.carmot-therapeutics.us

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Other Pharmaceuticals and Biotechnology

Primary Office

409 Illinois Street San Francisco, CA 94158United States
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Carmot Therapeutics's full profile, request a free trial.

    Carmot Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Carmot Therapeutics Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Carmot Therapeutics Investors (5)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Leader VenturesLender/Debt ProviderMinority000 0000000 0000
    Michael J. Fox FoundationOther000 0000000 0000
    National Cancer InstituteGovernment000 0000000 0000
    National Science FoundationGovernment000 0000000 0000
    The Column GroupVenture CapitalMinority000 0000000 0000
    Leader Ventures Lender/Debt Provider
    Michael J. Fox Foundation Other
    National Cancer Institute Government
    National Science Foundation Government
    The Column Group Venture Capital

    Carmot Therapeutics Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    Stig Hansen Ph.DCo-Founder, Board Member & Chief Executive Officer
    Daniel Erlanson Ph.DCo-Founder, Vice President of Chemistry, Board Member & President
    Elena VibochDirector of Business Development and Operations,
    Stig Hansen Ph.D Co-Founder, Board Member & Chief Executive Officer
    Daniel Erlanson Ph.D Co-Founder, Vice President of Chemistry, Board Member & President
    Elena Viboch Director of Business Development and Operations,

    Carmot Therapeutics Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Aetna Trombley Ph.DSelfBoard Member000 0000
    David Goeddel Ph.DThe Column GroupManaging Partner000 0000
    Laurence Lasky Ph.DSelfBoard Member000 0000
    Magnus Persson MDSelfBoard Member000 0000
    Timothy Kutzkey Ph.DThe Column GroupManaging Partner000 0000
    Aetna Trombley Ph.D Board Member Self
    David Goeddel Ph.D Managing Partner The Column Group
    Laurence Lasky Ph.D Board Member Self
    Magnus Persson MD Board Member Self
    Timothy Kutzkey Ph.D Managing Partner The Column Group
    Request full access to PitchBook